High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Treatment of Ovarian Cancer

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.

What is the problem and what is known about it so far?

Most women with ovarian cancer that has spread outside the ovaries die of the cancer despite treatment; very few survive more than 2 years after the cancer spreads. Researchers are therefore developing new treatment strategies, including autologous stem-cell transplantation (ASCT). In ASCT, patients first receive strong …

This 100-word excerpt has been provided in the absence of an abstract.

| Table of Contents

This Article

  1. Ann Intern Med October 3, 2000 vol. 133 no. 7 I-24
  1. » ExcerptFREE

Comments

  1. Submit a comment
  2. No comments published

Share

Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement